Alps Advisors Inc Edgewise Therapeutics, Inc. Transaction History
Alps Advisors Inc
- $14.1 Billion
- Q1 2024
A detailed history of Alps Advisors Inc transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 65,672 shares of EWTX stock, worth $1.37 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
65,672
Previous 43,226
51.93%
Holding current value
$1.37 Million
Previous $472,000
153.6%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EWTX
# of Institutions
129Shares Held
76.3MCall Options Held
14.7KPut Options Held
14.8K-
Orbimed Advisors LLC San Diego, CA15MShares$314 Million6.17% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$122 Million1.35% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$84 Million0.0% of portfolio
-
Viking Global Investors LP3.34MShares$69.9 Million0.23% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.32B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...